Clinical Trials Browser

Esophageal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms, Esophagitis

Esophageal Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Diseases, Esophageal Neoplasms

Esophageal Neoplasms, Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Esophageal Neoplasms, Neoplasms

Esophageal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Carcinoma, Squamous Cell, Esophageal Neoplasms

Esophageal Neoplasms

Clinical Trials

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

A Study of Patients Receiving High-Dose Rate Brachytherapy

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

REVO

Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer

EXCEL

Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

Selective Dose Escalation for Esophageal Cancer